-
Forward Look
Second-Cancer Clues?Genetic marker discovery could help childhood Hodgkin survivors assess risks associated with radiation.
by Mitzi Baker
-
Staying the Course
Patients are increasingly skipping treatment breaks and opting for ongoing treatment known as maintenance therapy to try to keep some types of cancer at bay.
by Melissa Weber
-
Survivor Profile
When Cancer Meets Inner DriveDiagnosed at 28, Rochelle Shoretz has stayed true to her big dreams and to her goal of helping other young women with breast cancer.
by Yvonne Lee
-
The Wait for a Match
Many patients in urgent need of bone marrow or stem cell transplants are facing uncertainty.
by Karen Patterson
-
Forward Look
Avastin’s FateDebate goes on as FDA revokes drug's use for breast cancer.
by Alanna Kennedy-Gorman
-
Forward Look
A Burning Question for SmokersIs the considerable risk-reduction benefit of CT screening worth the potential downsides?
by Sue Rochman
-
Global Report
Stark Realities in ZambiaAn American cancer survivor's visit to a Southern African nation reveals how doctors are adapting cancer care to meet an overwhelming need.
by Cynthia Ryan
-
Yesterday & Today
A King’s LegacyMore than a quarter century after Yul Brynner's death from lung cancer, treatment advances offer some patients new options, but the cancer continues to claim more lives than any other. And the actor's haunting anti-smoking message lives on.
by Sue Rochman
Previous |
Cancer Talk
Lessons Learned as a Caregiver and Patient
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons